Drug Profile
Research programme: growth hormone-releasing hormone antagonists - Biscayne Pharmaceuticals
Alternative Names: BIS-1062; GHRH antagonists - BiscayneLatest Information Update: 21 Mar 2023
Price :
$50
*
At a glance
- Originator University of Miami
- Developer Biscayne Pharmaceuticals
- Class Hypothalamic hormones
- Mechanism of Action Growth hormone-releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Ovarian cancer; Prostate cancer
Most Recent Events
- 21 Mar 2023 Discontinued - Preclinical for Breast cancer in USA (Parenteral)
- 21 Mar 2023 Discontinued - Preclinical for Ovarian cancer in USA (Parenteral)
- 21 Mar 2023 Discontinued - Preclinical for Prostate cancer in USA (Parenteral)